Samoa
Diabetes country report 2011 — 2050
Number of adults (20–79 years) with diabetes in Samoa (WS)
2011 | 6.6 thousand |
2024 | 28.2 thousand |
2050 | 44.6 thousand |
Samoa is one of the 37 countries and territories in the Western Pacific Region. Samoa has the fourth highest prevalence of diabetes (20-79 years) in the world.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPS 2013
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 6.6 | 28.2 | 44.6 |
Age-standardised prevalence of diabetes, % | - | 7.7 | 25.4 | 27.2 |
Proportion of people with undiagnosed diabetes, % | - | - | 83.9 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 23.6 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 29.0 | 45.8 |
Age-standardised prevalence of IFG, % | - | - | 24.2 | 24.4 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 5.9 | 7.6 | 11.9 |
Age-standardised prevalence of IGT, % | - | 6.6 | 7.0 | 7.5 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 151.0 | 146.4 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 16.0 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 11.8 | 18.0 |
Total diabetes-related health expenditure, ID million | - | - | 18.5 | 28.2 |
Diabetes-related health expenditure per person, USD | - | 312.0 | 420.1 | 404.2 |
Diabetes-related health expenditure per person, ID | - | - | 656.3 | 631.5 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 7.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 3.2 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 93.0 | 119.0 | 185.1 |
Population of children and adolescents (0-19 y) | - | - | 105,983.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |